Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Pharmavite, FDA Offer Alternate Takes On GMP Compliance Strategy

This article was originally published in The Tan Sheet

Executive Summary

A Pharmavite executive outlined a “different perspective” from the conventional wisdom promoted by FDA on successful compliance with dietary supplement good manufacturing practices: an emphasis on finished product specifications.

You may also be interested in...

GMP Qualification And Testing Provisions Still Trip Supplement Firms

A year after the final step in the three-year rollout of the dietary supplement good manufacturing practices final rule, firms large and small are learning the hard way what FDA expects to find in a facility.

FDA's Reynolds Marks Top GMP Trouble Spots As Deadline Looms

Some dietary supplement firms will not be ready to comply with good manufacturing practices by the rapidly approaching final deadline, according to a senior FDA advisor on supplement products

Biden Administration Pause On Pending Trump-Era Rules Stalls FDA Cannabinoids Guidance Progress

Among four FDA regulatory items withdrawn from OMB review is “Cannabidiol Enforcement Policy; Draft Guidance for Industry,” which the agency submitted in July 2020.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts